SOLID DISPERSION COMPOSITION WITH INCREASED STABILITY COMPRISING AMORPHOUS SOLIFENACIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

摘要

In a solid dispersion composition comprising solifenacin or a pharmaceutically acceptable salt thereof, disclosed are a solid dispersion body composition and a manufacturing method thereof wherein the composition is configured to comprise only an amorphous form of solifenacin or a pharmaceutically acceptable salt thereof.